Your browser doesn't support javascript.
loading
Application of Ag nanoparticles decorated on graphene nanosheets for electrochemical sensing of CEA as an important cancer biomarker.
Yan, Ming; Fu, Ling-Ling; Feng, Hong-Chao; Namadchian, Melika.
Afiliação
  • Yan M; Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, 550002, Guizhou, China.
  • Fu LL; Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, 550002, Guizhou, China.
  • Feng HC; Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, 550002, Guizhou, China. Electronic address: hcfeng@gzu.edu.cn.
  • Namadchian M; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: m.namadchian@yahoo.com.
Environ Res ; 239(Pt 2): 117363, 2023 Dec 15.
Article em En | MEDLINE | ID: mdl-37838192
ABSTRACT
In this research, a novel biosensing platform is described based on graphene nano-sheets decorated with Ag nano-particles (GNSs@Ag NPs). The designed electrochemical aptasensor was employed to determine carcinoembryonic antigen (CEA), an important cancer biomarker. Inherently, aptasensing interfaces provide high sensitivity for CEA tumor marker because of the high specific surface area and excellent conductivity of the prepared GNSs@Ag NPs composite. The established assay demonstrated a wide linear range from 0.001 pg/mL to 10 pg/mL with a correlation coefficient of 0.9958 and low detection limit (DL) of 0.5 fg/mL based on S/N = 3 protocol. The derived biosensor illustrated acceptable selectivity towards common interfering species including HER2, VEGF, IgG, MUC1 and CFP10. In addition, the aptsensor showed good reproducibility and fast response time. The applicability of the suggested strategy in human serum samples was also examined and compared to the commercial enzyme-linked immunosorbent assay (ELISA). Based on the experimental data, it was found that the discussed sensing platform can be exerted in the monitoring of CEA in different cancers for early diagnosis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article